News and Press Releases
Tower announces the ‘Evolution’ of the pharmaceutical cold chain
The latest innovation from Tower Cold Chain, a pioneer in passive temperature-controlled containers, offers pharmaceutical manufacturers, airlines and 3PL providers a single solution compatible with US and EU pallets –...
Category: Logistics, Manufacturing and Packing
Posted: November 3, 2023
Unit A, Total Park, Station Road, Theale, Reading, Berkshire RG7 4PN, UK
Dr Björn Beckmann Appointed Head of Quality Control at Rentschler Biopharma’s Laupheim Site
31 October 2023 – Laupheim, Germany – Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, today announced that Dr Björn Beckmann has been promoted...
Category: BioManufacturing, Drug Delivery, Drug Discovery
Posted: October 31, 2023
Cytomos selected to showcase CDS cell analysis technology at BIA’s BioProcessUK Dragon’s Den session
23 October 2023 – Biotech company, Cytomos (www.cytomotos.com) is pleased to announce that it has been selected to showcase its dielectric spectroscopy (CDS) platform at the BIA’s BioProcessUK Dragon’s Den...
Category:
Posted: October 30, 2023
Middle Wing Building University of Edinburgh Easter Bush Campus Roslin EH25 9RG Scotland
Phastar Offers Pro Bono Support to Medicines Development for Global Health
Supporting medicine development for disadvantaged communities 26th October 2023 -- London, UK, and North Carolina, US -- Phastar, a global specialist biometrics contract research organisation (CRO), is offering pro bono support to...
Category: Other
Posted: October 30, 2023
Optibrium introduces cloud-based version of StarDrop drug discovery platform
Cloud-based version of StarDrop retains all the functionality and interactivity of desktop version with improved accessibility and lower total cost of ownership for customers Optibrium recently received ISO 27001 accreditation...
Category: Drug Delivery, Drug Discovery
Posted: October 27, 2023
Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK
Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology
REVeRT, a dual vector approach based on mRNA trans-splicing, enables delivery of genes larger than the usual AAV packaging size in various tissues Potential to address prevalent inherited diseases caused...
Category:
Posted: October 27, 2023
myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics
myNEO Therapeutics to focus on building proprietary product pipeline based on a novel class of shared therapeutic cancer targets derived from the dark genome named “camyotopes” Lead product CAMYO-01 incorporates...
Category: BioManufacturing, Drug Delivery
Posted: October 27, 2023
Commercial study set up times reduced by a third, according to new data
26 October 2023 -- London, England -- New data from the National Institute for Health and Care Research (NIHR) shows that the National Contract Value Review has significantly reduced the...
Category: Clinical Trials
Posted: October 26, 2023
Cambridge Cognition launches AQUA to automate quality assurance in CNS trials using speech analysis
25 October 2023 -- Cambridge, UK -- Cambridge Cognition, a leader in digital health solutions for brain health assessment, announces the launch of AQUA, an automated quality assurance solution for...
Category: Clinical Trials
Posted: October 26, 2023
Newly established 3PARL consortium to assure global life sciences industry of consistent high standard of GMP supply chain audits
Rephine and Eurofins Healthcare are acting against substandard audit practices with guarantees of the highest quality of inspection services & library reports, from raw materials to finished products 24 October...
Category: Other
Posted: October 25, 2023
Roquette completes the acquisition of Qualicaps and reinforces its global position in the pharmaceutical industry
This strategic investment creates a stronger leader, with an expanded global footprint, as well as an enriched offering of oral dosage solutions. 24 October 2023 -- La Madeleine, France, and...
Category: Drug Delivery, Manufacturing and Packing
Posted: October 24, 2023
Landmark Phase 3 MARIPOSA Study Shows RYBREVANT▼(amivantamab) Plus Lazertinib Resulted in 30% Reduction in Risk of Disease Progression or Death Compared to Osimertinib in Patients with EGFR-Mutated NSCLC
Early data show an overall survival trend favoring the combination of amivantamab and lazertinib compared to osimertinib; consistent results seen in patients with and without brain metastases Late-breaking results from...
Category: Clinical Trials
Posted: October 24, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Kite’s CAR T-Cell Therapy YESCARTA (Axicabtagene Ciloleucel) Compared with Bispecifics in R/R DLBCL in Two Analyses at ESMO 2023
23 October 2023 -- Stockley Park, UK -- Kite, a Gilead Company, today announced results from two indirect comparative analyses of its CAR T-cell therapy Yescarta (axicabtagene ciloleucel) versus bispecific...
Category: Clinical Trials
Posted: October 23, 2023
Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus Chemotherapy
Data from Cohort 1 of the phase 2 THOR-2 study showed oral erdafitinib reduced the risk of disease recurrence or death compared with intravesical standard-of-care chemotherapy 21 October 2023 --...
Category: Clinical Trials
Posted: October 23, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
European Commission Approves ADCETRIS (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
· Approval Based on Updated Positive Overall Survival Results from the phase 3 ECHELON-1 Study for Stage III & IV Hodgkin Lymphoma · First Significant Improvement in Overall Survival in Two Decades...
Category: Pharmaceutical
Posted: October 23, 2023
